Clinical Microbiology Newsletter
Volume 31, Issue 20 , Pages 153-160 , 15 October 2009

Epidemiology and Virulence of Community-Associated MRSA

  • Adam D. Kennedy, Ph.D.
  • ,
  • Frank R. DeLeo, Ph.D.

      Affiliations

    • Corresponding Author InformationCorresponding author: Frank R. DeLeo, Ph.D., Laboratory of Human Bacterial Pathogenesis, Rocky Mountain Laboratories, NIAID, NIH, 903 S. 4th St., Hamilton, MT 59840. Tel.: 406-363-9448

References 

  1. Moran GJ , et al.   Methicillin-resistant S. aureus infections among patients in the emergency department . N. Engl. J. Med. . 2006;355:666–674
  2. Styers D , et al.   Laboratory-based surveillance of current antimicrobial resistance patterns and trends among Staphylococcus aureus: 2005 status in the United States . Ann. Clin. Microbiol. Antimicrob. . 2006;5:2
  3. von Eiff EC , et al.   Nasal carriage as a source of Staphylococcus aureus bacteremia . N. Engl. J. Med. . 2001;344:11–16
  4. Williams RE , et al.   Nasal staphylococci and sepsis in hospital patients . Br. Med. J. . 1959;2:658–662
  5. Jevons MP , Parker MT . The evolution of new hosptial strains of Staphylococcus aureus . J. Clin. Pathol. . 1964;17:243–250
  6. Fergie JE , Purcell K . Community-acquired methicillin-resistant Staphylococcus aureus infections in south Texas children . Pediatr. Infect. Dis. J. . 2001;20:860–863
  7. Adcock PM , et al.   Methicillin-resistant Staphylococcus aureus in two child care centers . J. Infect. Dis. . 1998;178:577–580
  8. Aiello AE , et al.   Methicillin-resistant Staphylococcus aureus among US prisoners and military personnel: review and recommendations for future studies . Lancet Infect. Dis. . 2006;6:335–341
  9. Centers for Disease Control and Prevention  . Public health dispatch: outbreaks of community-associated methicillin-resistant Staphylococcus aureus skin infections — Los Angeles County, California, 2002-2003 . JAMA . 2003;289:1377
  10. Methicillin-resistant Staphylococcus aureus infections among competitive sports participants—Colorado, Indiana, Pennsylvania, and Los Angeles County, 2000-2003 . MMWR Morb. Mortal. Wkly. Rep. . 2003;52:793–795
  11. Kazakova SV , et al.   A clone of methicillin-resistant Staphylococcus aureus among professional football players . N. Engl. J. Med. . 2005;352:468–475
  12. Nguyen DM , et al.   Recurring methicillin-resistant Staphylococcus aureus infections in a football team . Emerg. Infect. Dis. . 2005;11:526–532
  13. Zinderman CE , et al.   Community-acquired methicillin-resistant Staphylococcus aureus among military recruits . Emerg. Infect. Dis. . 2004;10:941–944
  14. Kaplan SL , et al.   Three-year surveillance of community-acquired Staphylococcus aureus infections in children . Clin. Infect. Dis. . 2005;40:1785–1791
  15. Fridkin SK , et al.   Methicillin-resistant Staphylococcus aureus disease in three communities . N. Engl. J. Med. . 2005;352:1436–1444
  16. Adem PV , et al.   Staphylococcus aureus sepsis and the Waterhouse-Friderichsen syndrome in children . N. Engl. J. Med. . 2005;353:1245–1251
  17. Francis JS , et al.   Severe community-onset pneumonia in healthy adults caused by methicillin-resistant Staphylococcus aureus carrying the Panton-Valentine leukocidin genes . Clin. Infect. Dis. . 2005;40:100–107
  18. Hageman JC , et al.   Severe community-acquired pneumonia due to Staphylococcus aureus, 2003-04 influenza season . Emerg. Infect. Dis. . 2006;12:894–899
  19. Centers for Disease Control and Prevention  . Four pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus—Minnesota and North Dakota, 1997-1999 . JAMA . 1999;282:1123–1125
  20. Mishaan AM , et al.   Emergence of a predominant clone of community-acquired Staphylococcus aureus among children in Houston, Texas . Pediatr. Infect. Dis. J. . 2005;24:201–206
  21. Miller LG , et al.   Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles . N. Engl. J. Med. . 2005;352:1445–1453
  22. Jevons MP . “Celbenin”-resistant staphylococci . Br. Med. J. . 1961;1:124–125
  23. Klevens RM , et al.   Methicillin-resistant Staphylococcus aureus: a primer for dentists . J. Am. Dent. Assoc. . 2008;139:1328–1337
  24. Chambers HF . Solving staphylococcal resistance to beta-lactams . Trends Microbiol. . 2003;11:145–148
  25. Diep BA , et al.   Complete genome sequence of USA300, an epidemic clone of community-acquired methicillin-resistant Staphylococcus aureus . Lancet . 2006;367:731–739
  26. Cosgrove SE , Fowler VG . Management of methicillin-resistant Staphylococcus aureus bacteremia . Clin. Infect. Dis. . 2008;46(Suppl. 5):S386–S393
  27. Corey GR . Staphylococcus aureus bloodstream infections: definitions and treatment . Clin. Infect. Dis. . 2009;48(Suppl. 4):S254–S259
  28. Moellering RC . Current treatment options for community-acquired methicillin-resistant Staphylococcus aureus infection . Clin. Infect. Dis. . 2008;46:1032–1037
  29. Noel GJ , et al.   Results of a double-blind, randomized trial of ceftobiprole treatment of complicated skin and skin structure infections caused by gram-positive bacteria . Antimicrob. Agents Chemother. . 2008;52:37–44
  30. Jauregui LE , et al.   Randomized, double-blind comparison of once-weekly dalbavancin versus twice-daily linezolid therapy for the treatment of complicated skin and skin structure infections . Clin. Infect. Dis. . 2005;41:1407–1415
  31. Mercier RC , et al.   Effect of growth phase and pH on the in vitro activity of a new glycopeptide, oritavancin (LY333328), against Staphylococcus aureus and Enterococcus faecium . J. Antimicrob. Chemother. . 2002;50:19–24
  32. Stryjewski ME , et al.   Telavancin versus vancomycin for the treatment of complicated skin and skin-structure infections caused by gram-positive organisms . Clin. Infect. Dis. . 2008;46:1683–1693
  33. Sader HS , et al.   Tigecycline activity tested against 26,474 bloodstream infection isolates: a collection from 6 continents . Diagn. Microbiol. Infect. Dis. . 2005;52:181–186
  34. Stryjewski ME , Chambers HF . Skin and soft-tissue infections caused by community-acquired methicillin-resistant Staphylococcus aureus . Clin. Infect. Dis. . 2008;46(Suppl. 5):S368–S377
  35. Udo EE , et al.   Genetic analysis of community isolates of methicillin-resistant Staphylococcus aureus in Western Australia . J. Hosp. Infect. . 1993;25:97–108
  36. Herold BC , et al.   Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk . JAMA . 1998;279:593–598
  37. McDougal LK , et al.   Pulsed-field gel electrophoresis typing of oxacillin-resistant Staphylococcus aureus isolates from the United States: establishing a national database . J. Clin. Microbiol. . 2003;41:5113–5120
  38. Baba T , et al.   Genome and virulence determinants of high virulence community-acquired MRSA . Lancet . 2002;359:1819–1827
  39. Mulvey MR , et al.   Community-associated methicillin-resistant Staphylococcus aureus, Canada . Emerg. Infect. Dis. . 2005;11:844–850
  40. Zhang K , et al.   Coexistence of Panton-Valentine leukocidin-positive and -negative community-associated methicillin-resistant Staphylococcus aureus USA400 sibling strains in a large Canadian health-care region . J. Infect. Dis. . 2008;197:195–204
  41. King MD , et al.   Emergence of community-acquired methicillin-resistant Staphylococcus aureus USA 300 clone as the predominant cause of skin and soft-tissue infections . Ann. Intern. Med. . 2006;144:309–317
  42. Liu C , et al.   A population-based study of the incidence and molecular epidemiology of methicillin-resistant Staphylococcus aureus disease in San Francisco, 2004-2005 . Clin. Infect. Dis. . 2008;46:1637–1646
  43. Tristan A , et al.   Global distribution of Panton-Valentine leukocidin—positive methicillin-resistant Staphylococcus aureus, 2006 . Emerg. Infect. Dis. . 2007;13:594–600
  44. Ferry T , Etienne J . Community acquired MRSA in Europe . BMJ . 2007;335:947–948
  45. Robert J , et al.   Methicillin-resistant Staphylococcus aureus producing Panton-Valentine leukocidin in a retrospective case series from 12 French hospital laboratories, 2000-2003 . Clin. Microbiol. Infect. . 2005;11:585–587
  46. Arias CA , et al.   MRSA USA300 clone and VREF — a U.S.-Colombian connection? . N. Engl. J. Med. . 2008;359:2177–2179
  47. Larsen AR , et al.   Emergence and characterization of community-associated methicillin-resistant Staphyloccocus aureus infections in Denmark, 1999 to 2006 . J. Clin. Microbiol. . 2009;47:73–78
  48. Rossney AS , et al.   The emergence and importation of diverse genotypes of methicillin-resistant Staphylococcus aureus (MRSA) harboring the Panton-Valentine leukocidin gene (pvl) reveal that pvl is a poor marker for community-acquired MRSA strains in Ireland . J. Clin. Microbiol. . 2007;45:2554–2563
  49. Fang H , et al.   Genetic diversity of community-associated methicillin-resistant Staphylococcus aureus in southern Stockholm, 2000-2005 . Clin. Microbiol. Infect. . 2008;14:370–376
  50. Harbarth S , et al.   Community-associated methicillin-resistant Staphylococcus aureus, Switzerland . Emerg. Infect. Dis. . 2005;11:962–965
  51. Coombs GW , et al.   Genetic diversity among community methicillin-resistant Staphylococcus aureus strains causing outpatient infections in Australia . J. Clin. Microbiol. . 2004;42:4735–4743
  52. Begier EM , et al.   A high-morbidity outbreak of methicillin-resistant Staphylococcus aureus among players on a college football team, facilitated by cosmetic body shaving and turf burns . Clin. Infect. Dis. . 2004;39:1446–1453
  53. Gorwitz RJ , et al.   Changes in the prevalence of nasal colonization with Staphylococcus aureus in the United States, 2001-2004 . J. Infect. Dis. . 2008;197:1226–1234
  54. Groom AV , et al.   Community-acquired methicillin-resistant Staphylococcus aureus in a rural American Indian community . JAMA . 2001;286:1201–1205
  55. Coronado F , et al.   Community-associated methicillin-resistant Staphylococcus aureus skin infections in a religious community . Epidemiol. Infect. . 2007;135:492–501
  56. Voss A , et al.   Methicillin-resistant Staphylococcus aureus in pig farming . Emerg. Infect. Dis. . 2005;11:1965–1966
  57. Bhat M , et al.   Staphylococcus aureus ST398, New York City and Dominican Republic . Emerg. Infect. Dis. . 2009;15:285–287
  58. Smith TC , et al.   Methicillin-resistant Staphylococcus aureus (MRSA) strain ST398 is present in midwestern U.S. swine and swine workers . PLoS. ONE . 2008;4:e4258
  59. Khanna T , et al.   Methicillin resistant Staphylococcus aureus colonization in pigs and pig farmers . Vet. Microbiol. . 2008;128:298–303
  60. van Loo I , et al.   Emergence of methicillin-resistant Staphylococcus aureus of animal origin in humans . Emerg. Infect. Dis. . 2007;13:1834–1839
  61. Nemati M , et al.   Antimicrobial resistance of old and recent Staphylococcus aureus isolates from poultry: first detection of livestock-associated methicillin-resistant strain ST398 . Antimicrob. Agents Chemother. . 2008;52:3817–3819
  62. Weese JS , et al.   Community-associated methicillin-resistant Staphylococcus aureus in horses and humans who work with horses . J. Am. Vet. Med. Assoc. . 2005;226:580–583
  63. Li M , et al.   Evolution of virulence in epidemic community-associated methicillin-resistant Staphylococcus aureus . Proc. Natl. Acad. Sci. USA . 2009;106:5883–5888
  64. Weese JS , et al.   An outbreak of methicillin-resistant Staphylococcus aureus skin infections resulting from horse to human transmission in a veterinary hospital . Vet. Microbiol. . 2006;114:160–164
  65. Vitale CB , et al.   Methicillin-resistant Staphylococcus aureus in cat and owner . Emerg. Infect. Dis. . 2006;12:1998–2000
  66. Robinson DA , Enright MC . Evolution of Staphylococcus aureus by large chromosomal replacements . J. Bacteriol. . 2004;186:1060–1064
  67. Feil EJ , et al.   How clonal is Staphylococcus aureus? . J. Bacteriol. . 2003;185:3307–3316
  68. Robinson DA , Enright MC . Evolutionary models of the emergence of methicillin-resistant Staphylococcus aureus . Antimicrob. Agents Chemother. . 2003;47:3926–3934
  69. Enright MC , et al.   The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA) . Proc. Natl. Acad. Sci. USA . 2002;99:7687–7692
  70. Lindsay JA , et al.   Microarrays reveal that each of the ten dominant lineages of Staphylococcus aureus has a unique combination of surface-associated and regulatory genes . J. Bacteriol. . 2006;188:669–676
  71. Enright MC , et al.   Multilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of Staphylococcus aureus . J. Clin. Microbiol. . 2000;38:1008–1015
  72. Shopsin B , et al.   Evaluation of protein A gene polymorphic region DNA sequencing for typing of Staphylococcus aureus strains . J. Clin. Microbiol. . 1999;37:3556–3563
  73. Kennedy AD , et al.   Epidemic community-associated methicillin-resistant Staphylococcus aureus: recent clonal expansion and diversification . Proc. Natl. Acad. Sci. USA . 2008;105:1327–1332
  74. Bens CC , et al.   Presence of a novel DNA methylation enzyme in methicillin-resistant Staphylococcus aureus isolates associated with pig farming leads to uninterpretable results in standard pulsed-field gel electrophoresis analysis . J. Clin. Microbiol. . 2006;44:1875–1876
  75. Ito T , et al.   Structural comparison of three types of staphylococcal cassette chromosome mec integrated in the chromosome in methicillin-resistant Staphylococcus aureus . Antimicrob. Agents Chemother. . 2001;45:1323–1336
  76. Katayama Y , et al.   A new class of genetic element, staphylococcus cassette chromosome mec, encodes methicillin resistance in Staphylococcus aureus . Antimicrob. Agents Chemother. . 2000;44:1549–1555
  77. Daum RS , et al.   A novel methicillin-resistance cassette in community-acquired methicillin-resistant Staphylococcus aureus isolates of diverse genetic backgrounds . J. Infect. Dis. . 2002;186:1344–1347
  78. Ma XX , et al.   Novel type of staphylococcal cassette chromosome mec identified in community-acquired methicillin-resistant Staphylococcus aureus strains . Antimicrob. Agents Chemother. . 2002;46:1147–1152
  79. de Lencastre H , et al.   Antibiotic resistant Staphylococcus aureus: a paradigm of adaptive power . Curr. Opin. Microbiol. . 2007;10:428–435
  80. Musser JM , Kapur V . Clonal analysis of methicillin-resistant Staphylococcus aureus strains from intercontinental sources: association of the mec gene with divergent phylogenetic lineages implies dissemination by horizontal transfer and recombination . J. Clin. Microbiol. . 1992;30:2058–2063
  81. Fitzgerald JR , et al.   Evolutionary genomics of Staphylococcus aureus: insights into the origin of methicillin-resistant strains and the toxic shock syndrome epidemic . Proc. Natl. Acad. Sci. USA . 2001;98:8821–8826
  82. Nubel U , et al.   Frequent emergence and limited geographic dispersal of methicillin-resistant Staphylococcus aureus . Proc. Natl. Acad. Sci. USA . 2008;105:14130–14135
  83. Okuma K , et al.   Dissemination of new methicillin-resistant Staphylococcus aureus clones in the community . J. Clin. Microbiol. . 2002;40:4289–4294
  84. Lee SM , et al.   Fitness cost of staphylococcal cassette chromosome mec in methicillin-resistant Staphylococcus aureus by way of continuous culture . Antimicrob. Agents Chemother. . 2007;51:1497–1499
  85. Maree CL , et al.   Community-associated methicillin-resistant Staphylococcus aureus isolates causing healthcare-associated infections . Emerg. Infect. Dis. . 2007;13:236–242
  86. Seybold U , et al.   Emergence of community-associated methicillin-resistant Staphylococcus aureus USA300 genotype as a major cause of health care-associated blood stream infections . Clin. Infect. Dis. . 2006;42:647–656
  87. Popovich KJ , et al.   Are community-associated methicillin-resistant Staphylococcus aureus (MRSA) strains replacing traditional nosocomial MRSA strains? . Clin. Infect. Dis. . 2008;46:787–794
  88. D'Agata EM , et al.   Modeling the invasion of community-acquired methicillin-resistant Staphylococcus aureus into hospitals . Clin. Infect. Dis. . 2009;48:274–284
  89. Wiese-Posselt M , et al.   Successful termination of a furunculosis outbreak due to lukS-lukF-positive, methicillin-susceptible Staphylococcus aureus in a German village by stringent decolonization, 2002-2005 . Clin. Infect. Dis. . 2007;44:e88–e95
  90. DeLeo FR , et al.   Host defense and pathogenesis in Staphylococcus aureus infections . Infect. Dis. Clin. N. Am. . 2009;23:17–34
  91. Voyich JM , et al.   Insights into mechanisms used by Staphylococcus aureus to avoid destruction by human neutrophils . J. Immunol. . 2005;175:3907–3919
  92. Palazzolo-Ballance AM , et al.   Neutrophil microbicides induce a pathogen survival response in community-associated methicillin-resistant Staphylococcus aureus . J. Immunol. . 2008;180:500–509
  93. Vandenesch F , et al.   Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence . Emerg. Infect. Dis. . 2003;9:978–984
  94. Lina G , et al.   Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia . Clin. Infect. Dis. . 1999;29:1128–1132
  95. Gillet Y , et al.   Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients . Lancet . 2002;359:753–759
  96. Panton PN , Valentine FCO . Staphylococcal toxin . Lancet . 1932;i:506–508
  97. Szmigielski S , et al.   Reaction of rabbit leucocytes to staphylococcal (Panton-Valentine) leucocidin in vivo . J. Pathol. Bacteriol. . 1966;91:599–604
  98. Grojec PL , Jeljaszewicz J . Effect of staphylococcal leukocidin on mouse leukocyte system . Zentralbl. Bakteriol. Mikrobiol. Hyg. A . 1981;250:446–455
  99. Holmes A , et al.   Staphylococcus aureus isolates carrying Panton-Valentine leucocidin genes in England and Wales: frequency, characterization, and association with clinical disease . J. Clin. Microbiol. . 2005;43:2384–2390
  100. O'Brien FG , et al.   Diversity among community isolates of methicillin-resistant Staphylococcus aureus in Australia . J. Clin. Microbiol. . 2004;42:3185–3190
  101. Kim ES , et al.   A survey of community-associated methicillin-resistant Staphylococcus aureus in Korea . J. Antimicrob. Chemother. . 2007;60:1108–1114
  102. Voyich JM , et al.   Is Panton-Valentine leukocidin the major virulence determinant in community-associated methicillin-resistant Staphylococcus aureus disease? . J. Infect. Dis. . 2006;194:1761–1770
  103. Bubeck Wardenburg J , et al.   Poring over pores: alpha-hemolysin and Panton-Valentine leukocidin in Staphylococcus aureus pneumonia . Nat. Med. . 2007;13:1405–1406
  104. Bubeck Wardenburg J , et al.   Panton-Valentine leukocidin is not a virulence determinant in murine models of community-associated methicillin-resistant Staphylococcus aureus disease . J. Infect. Dis. . 2008;198:1166–1170
  105. Montgomery CP , et al.   Comparison of virulence in community-associated methicillin-resistant Staphylococcus aureus pulsotypes USA300 and USA400 in a rat model of pneumonia . J. Infect. Dis. . 2008;198:561–570
  106. Labandeira-Rey M , et al.   Staphylococcus aureus Panton-Valentine leukocidin causes necrotizing pneumonia . Science . 2007;315:1130–1133
  107. Diep BA , et al.   Contribution of Panton-Valentine leukocidin in community-associated methicillin-resistant Staphylococcus aureus pathogenesis . PLoS ONE . 2008;3:e3198
  108. Villaruz AE , et al.   A point mutation in the agr locus rather than expression of the Panton-Valentine leukocidin caused previously reported phenotypes in Staphylococcus aureus pneumonia and gene regulation . J. Infect. Dis. . 2009;
  109. Brown EL , et al.   The Panton-Valentine leukocidin vaccine protects mice against lung and skin infections caused by Staphylococcus aureus USA300 . Clin. Microbiol. Infect. . 2009;15:156–164
  110. Diep BA , et al.   The arginine catabolic mobile element and staphylococcal chromosomal cassette mec linkage: convergence of virulence and resistance in the USA300 clone of methicillin-resistant Staphylococcus aureus . J. Infect. Dis. . 2008;197:1523–1530
  111. Montgomery CP , et al.   The arginine catabolic mobile element (ACME) is not associated with enhanced virulence in experimental invasive disease caused by the community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) genetic background USA300 . Infect. Immun. . 2009;77:2650–2656
  112. Bhakdi S , Tranum-Jensen J . Alpha-toxin of Staphylococcus aureus . Microbiol. Rev. . 1991;55:733–751
  113. Menzies BE , Kernodle DS . Site-directed mutagenesis of the alpha-toxin gene of Staphylococcus aureus: role of histidines in toxin activity in vitro and in a murine model . Infect. Immun. . 1994;62:1843–1847
  114. Bubeck WJ , et al.   Surface proteins and exotoxins are required for the pathogenesis of Staphylococcus aureus pneumonia . Infect. Immun. . 2007;75:1040–1044
  115. Bubeck Wardenburg J , Schneewind O . Vaccine protection against Staphylococcus aureus pneumonia . J. Exp. Med. . 2008;205:287–294
  116. Bartlett AH , et al.   Alpah-toxin facilitates the generation of CXC chemokine gradients and stimulates neutrophil homing in Staphylococcus aureus pneumonia . J. Infect. Dis. . 2008;198:1529–1535
  117. Wang R , et al.   Identification of novel cytolytic peptides as key virulence determinants for community-associated MRSA . Nat. Med. . 2007;13:1510–1514
  118. Ito T , et al.   Novel type V staphylococcal cassette chromosome mec driven by a novel cassette chromosome recombinase, ccrC . Antimicrob. Agents Chemother. . 2004;48:2637–2651
  119. Oliveira DC , et al.   Redefining a structural variant of staphylococcal cassette chromosome mec, SCCmec type VI . Antimicrob. Agents Chemother. . 2006;50:3457–3459
  120. Higuchi W , et al.   Structure and specific detection of staphylococcal cassette chromosome mec type VII . Biochem. Biophys. Res. Commun. . 2008;377:752–756
  121. Chongtrakool P , et al.   Staphylococcal cassette chromosome mec (SCCmec) typing of methicillin-resistant Staphylococcus aureus strains isolated in 11 Asian countries: a proposal for a new nomenclature for SCCmec elements . Antimicrob. Agents Chemother. . 2006;50:1001–1012

PII: S0196-4399(09)00046-4

doi: 10.1016/j.clinmicnews.2009.09.004

Clinical Microbiology Newsletter
Volume 31, Issue 20 , Pages 153-160 , 15 October 2009